About Aesculap
Aesculap is a Healthcare company based in Tuttlingen (Germany) founded in 1867, and was acquired by B Braun in June 1996. Surgical instruments and implants are supplied for medical procedures. It operates on a B2B2C and Professional Services model. Its chief executive, as recorded, is Jean Claude Dubacher. Aesculap offers products and services including Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery. Its focus areas include Medical Devices and Surgical Equipment. Its legal entity is B. Braun SE.
Company details
Aesculap, a key brand under B. Braun SE, is dedicated to providing innovative surgical and interventional solutions. The company is engaged in developing products and services for core surgical processes, including minimally invasive surgery, orthopaedic surgery, and neurosurgery. Solutions are offered across various sectors such as infection prevention, infusion therapy, and wound management. Smart infusion management and surgical asset management are also provided to enhance healthcare delivery. With a presence in multiple therapeutic areas, Aesculap is committed to protecting and improving patient health globally.
Products & Services of Aesculap
Aesculap offers a comprehensive portfolio of products and services, including Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery.
Surgical instruments are provided for various medical procedures.
Solutions for minimally invasive surgery are offered here.
Orthopaedic surgery solutions are developed for patient care.
Apps and channels of Aesculap
its YouTube channel B. Braun Deutschland has 17.2K subscribers and 30 videos.
Videos from Aesculap
The most watched videos on Aesculap's YouTube channel, B. Braun Deutschland (17.2K subscribers). Click a video to play it here.
More on B. Braun Deutschland.
Investors in Aesculap
Aesculap has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include B. Braun.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
B. Braun is recognized as a leading medical technology company. | 1839 | bbraun.com | Melsungen, Germany |
Investor details for Aesculap
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Aesculap
1 people are tracked at Aesculap (1 in leadership).
| Name | Role | Group |
|---|---|---|
Jean Claude Dubacher | CEO | Leadership |
Complete people profiles for Aesculap
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Aesculap
2 dated milestones of Aesculap across 129 years, from founding to its latest funding, stage changes and deals.
- Founded Aesculap is founded.
- Exit Acquired by B Braun.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Aesculap
Aesculap was founded in 1867.
Aesculap is headquartered in Tuttlingen, Germany. It is registered at Tuttlingen, Baden-wurttemberg, Germany.
Jean Claude Dubacher is the CEO of Aesculap, as recorded in our data.
Aesculap, a key brand under B. Braun SE, is dedicated to providing innovative surgical and interventional solutions. The company is engaged in developing products and services for core surgical processes, including minimally invasive surgery, orthopaedic surgery, and neurosurgery. Solutions are offered across various sectors such as infection prevention, infusion therapy, and wound management. Smart infusion management and surgical asset management are also provided to enhance healthcare delivery. With a presence in multiple therapeutic areas, Aesculap is committed to protecting and improving patient health globally.
Aesculap offers Surgical Instruments, Minimally Invasive Surgery, and Orthopaedic Surgery.
Aesculap has 1 investor. Key investors include B. Braun.
Aesculap operates through B. Braun Se.
Yes. Aesculap was acquired by B Braun in June 1996.